Skip to main content

Table 6 Adverse drug events with respect to class of prescribed antibiotics (N = 486)

From: Causality and preventability assessment of adverse drug events of antibiotics among inpatients having different lengths of hospital stay: a multicenter, cross-sectional study in Lahore, Pakistan

Antibiotics

ATC code

Definitely preventable ADEs

Probably preventable ADEs

Non-preventable ADEs

Long LOS, N = 171, n (%)

Short LOS, N = 41, n (%)

Total, N = 212, n (%)

Long LOS, N = 56, n (%)

Short LOS, N = 16, n (%)

Total, N = 72,

n (%)

Long LOS, N = 156, n (%)

Short LOS, N = 46, n (%)

Total, N = 202, n (%)

β - Lactams

 Penicillins

J01C

25 (14.6)

0 (0.0)

25 (11.8)

9 (16.1)

0 (0.0)

9 (12.5)

28 (17.9)

0 (0.0)

28 (13.9)

 Carbapenem

J01DH

11 (6.4)

7 (17.1)

18 (8.5)

2 (3.6)

0 (0.0)

2 (2.8)

12 (7.7)

2 (4.4)

14 (6.9)

 Cephalosporins

J01D

26 (15.2)

5 (12.2)

31 (14.6)

6 (10.7)

0 (0.0)

6 (8.3)

19 (12.2)

10 (21.7)

29 (14.4)

Total β – Lactams

62 (36.2)

12 (29.3)

74 (34.9)

17 (30.4)

0 (0.0)

17 (23.6)

59 (37.8)

12 (26.1)

71 (35.2)

Non- β Lactams

 Flouroquinolones

J01 M

18 (10.5)

3 (7.3)

21 (9.9)

7 (12.5)

6 (37.5)

13 (18.1)

19 (12.2)

8 (17.4)

27 (13.4)

 Aminoglycosides

J01G

13 (7.6)

3 (7.3)

16 (7.6)

6 (10.7)

0 (0.0)

6 (8.3)

13 (8.3)

2 (4.4)

15 (7.4)

 Tetracyclines

J01AA

12 (7.0)

1 (2.4)

13 (6.1)

5 (8.9)

3 (18.8)

8 (11.1)

12 (7.7)

3 (6.5)

15 (7.4)

 Macrolides

J01FA

27 (15.8)

4 (9.8)

31 (14.6)

4 (7.1)

0 (0.0)

4 (5.6)

25 (16.0)

1 (2.2)

26 (12.9)

 Lincosamide

J01FF

4 (2.3)

1 (2.4)

5 (2.4)

10 (17.8)

0 (0.0)

10 (13.9)

7 (4.5)

4 (8.7)

11 (5.5)

 Glycopeptide

J01XA

9 (5.3)

8 (19.5)

17 (8.0)

2 (3.6)

2 (12.5)

4 (5.6)

8 (5.1)

8 (17.4)

16 (7.9)

 Oxazolidones

J01XX

13 (7.6)

3 (7.3)

16 (7.6)

1 (1.8)

3 (18.8)

4 (5.6)

6 (3.9)

3 (6.5)

9 (4.5)

 Imidazole derivatives

G01AF

13 (7.6)

6 (14.6)

19 (8.9)

4 (7.1)

2 (12.5)

6 (8.3)

7 (4.5)

5 (10.9)

12 (5.9)

Total Non β – Lactams

109 (63.7)

29 (70.7)

138(65.1)

39 (69.6)

16(100.0)

55 (76.4)

97 (62.2)

34 (73.9)

131(64.9)

  1. ATC Anatomical Therapeutic Chemical Classification System, ADEs Adverse drug events, LOS Length of stay